Avalo Therapeutics AVTX Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's common stock, shares, outstanding?
- Avalo Therapeutics (AVTX) reported common stock, shares, outstanding of $24.64M in Q1 2026.
- How has Avalo Therapeutics's common stock, shares, outstanding changed year-over-year?
- Avalo Therapeutics's common stock, shares, outstanding increased by 127.5% year-over-year, from $10.83M to $24.64M.
- What is the long-term trend for Avalo Therapeutics's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Avalo Therapeutics's common stock, shares, outstanding has grown at a -24.4% compound annual growth rate (CAGR), from $75M to $18.51M.